Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Cancer research

Results: 1-25/1052

Authors: Weisburger, JH
Citation: Jh. Weisburger, Nicholas E. Geacintov, Suse Broyde, Brian Hingerty, Monique Cosman, ShantuAmin, and Dinshaw J. Patel - Cover legend, CANCER RES, 59(9), 1999, pp. NIL_16-NIL_16

Authors: Bao, SD Chang, MS Auclair, D Sun, YP Wang, YB Wong, WK Zhang, JY Liu, Y Qian, XQ Sutherland, R Magi-Galluzi, C Weisberg, E Cheng, EYS Hao, LN Sasaki, H Campbell, MS Kraeft, SK Loda, M Lo, KM Chen, LB
Citation: Sd. Bao et al., HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint generad17, is overexpressed in colon carcinoma, CANCER RES, 59(9), 1999, pp. 2023-2028

Authors: Deng, GR Chen, AD Hong, J Chae, HS Kim, YS
Citation: Gr. Deng et al., Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression, CANCER RES, 59(9), 1999, pp. 2029-2033

Authors: Gil, J Yamamoto, H Zapata, JM Reed, JC Perucho, M
Citation: J. Gil et al., Impairment of the proapoptotic activity of Bax by missense mutations foundin gastrointestinal cancers, CANCER RES, 59(9), 1999, pp. 2034-2037

Authors: Bryce, SD Forsyth, NR Fitzsimmons, SA Clark, LJ Bertram, MJ Cuthbert, AP Newbold, RF Pereira-Smith, OM Parkinson, EK
Citation: Sd. Bryce et al., Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene, CANCER RES, 59(9), 1999, pp. 2038-2040

Authors: Tanaka, T Kimura, M Matsunaga, K Fukada, D Mori, H Okano, Y
Citation: T. Tanaka et al., Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast, CANCER RES, 59(9), 1999, pp. 2041-2044

Authors: Nishikawa, A Furukawa, F Lee, IS Kasahara, K Tanakamaru, Z Nakamura, H Miyauchi, M Kinae, N Hirose, M
Citation: A. Nishikawa et al., Promoting effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone on rat glandular stomach carcinogenesis initiated with N-methyl-N '-nitro-N-nitrosoguanidine, CANCER RES, 59(9), 1999, pp. 2045-2049

Authors: Weinberg, WC Fernandez-Salas, E Morgan, DL Shalizi, A Mirosh, E Stanulis, E Deng, CX Hennings, H Yuspa, SH
Citation: Wc. Weinberg et al., Genetic deletion of p21(WAF1) enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis, CANCER RES, 59(9), 1999, pp. 2050-2054

Authors: Advani, SJ Chung, SM Yan, SY Gillespie, GY Markert, JM Whitley, RJ Roizman, B Weichselbaum, RR
Citation: Sj. Advani et al., Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors, CANCER RES, 59(9), 1999, pp. 2055-2058

Authors: Du, W Lebowitz, PF Prendergast, GC
Citation: W. Du et al., Elevation of alpha 2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltansferase inhibitors, CANCER RES, 59(9), 1999, pp. 2059-2063

Authors: Pan, Y Haines, DS
Citation: Y. Pan et Ds. Haines, The pathway regulating MDM2 protein degradation can be altered in human leukemic cells, CANCER RES, 59(9), 1999, pp. 2064-2067

Authors: Herranz, M Santos, J Salido, E Fernandez-Piqueras, J Serrano, M
Citation: M. Herranz et al., Mouse p73 gene maps to the distal part of chromosome 4 and might be involved in the progression of gamma-radiation-induced T-cell lymphomas, CANCER RES, 59(9), 1999, pp. 2068-2071

Authors: Shi, Q Huang, SY Jiang, WD Kutach, LS Ananthaswamy, HN Xie, KP
Citation: Q. Shi et al., Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53, CANCER RES, 59(9), 1999, pp. 2072-2075

Authors: Gillespie, GY Soroceanu, L Manning, TJ Gladson, CL Rosenfeld, SS
Citation: Gy. Gillespie et al., Glioma migration can be blocked by nontoxic inhibitors of myosin II, CANCER RES, 59(9), 1999, pp. 2076-2082

Authors: Bantel, H Engels, IH Voelter, W Schulze-Osthoff, K Wesselborg, S
Citation: H. Bantel et al., Mistletoe lectin activates caspase-8/FLICE independently of death receptorsignaling and enhances anticancer drug-induced apoptosis, CANCER RES, 59(9), 1999, pp. 2083-2090

Authors: Terashima, I Suzuki, N Shibutani, S
Citation: I. Terashima et al., Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen, CANCER RES, 59(9), 1999, pp. 2091-2095

Authors: Richards, J Auger, J Peace, D Gale, D Michel, J Koons, A Haverty, T Zivin, R Jolliffe, L Bluestone, JA
Citation: J. Richards et al., Phase I evaluation of humanized OKT3: Toxicity and immunomodulatory effects of hOKT3 gamma(4), CANCER RES, 59(9), 1999, pp. 2096-2101

Authors: Moreland, NJ Illand, M Kim, YT Paul, J Brown, R
Citation: Nj. Moreland et al., Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin, CANCER RES, 59(9), 1999, pp. 2102-2106

Authors: Sampath, P Hanes, J DiMeco, F Tyler, BM Brat, D Pardoll, DM Brem, H
Citation: P. Sampath et al., Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors, CANCER RES, 59(9), 1999, pp. 2107-2114

Authors: Gupta, S Ahmad, N Mohan, RR Husain, MM Mukhtar, H
Citation: S. Gupta et al., Prostate cancer chemoprevention by green tea: In vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase, CANCER RES, 59(9), 1999, pp. 2115-2120

Authors: Tai, YT Strobel, T Kufe, D Cannistra, SA
Citation: Yt. Tai et al., In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene, CANCER RES, 59(9), 1999, pp. 2121-2126

Authors: Weston, BW Hiller, KM Mayben, JP Manousos, GA Bendt, KM Liu, R Cusack, JC
Citation: Bw. Weston et al., Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells, CANCER RES, 59(9), 1999, pp. 2127-2135

Authors: Spitzweg, C Zhang, SB Bergert, ER Castro, MR McIver, B Heufelder, AE Tindall, DJ Young, CYF Morris, JC
Citation: C. Spitzweg et al., Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines, CANCER RES, 59(9), 1999, pp. 2136-2141

Authors: Vodovotz, Y Chesler, L Chong, HY Kim, SJ Simpson, JT DeGraff, W Cox, GW Roberts, AB Wink, DA Barcellos-Hoff, MH
Citation: Y. Vodovotz et al., Regulation of transforming growth factor beta 1 by nitric oxide, CANCER RES, 59(9), 1999, pp. 2142-2149

Authors: Fujii, S Fujimoto, K Shimizu, K Ezaki, T Kawano, F Takatsuki, K Kawakita, M Matsuno, K
Citation: S. Fujii et al., Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34(+) hematopoietic progenitor cells: Induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients, CANCER RES, 59(9), 1999, pp. 2150-2158
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>